🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objective: The main objective is to evaluate the pattern of dual antiplate...
Status
Unknown
Location
Hospital Germans Trias i Pujol
Start Date
2010-06
Trial ID
NCT01141153
Treatments Being Tested
Polypectomy is regarded as high risk for bleeding. Several guidelines recom...
Status
Completed
Location
Bucheon St. Mary's Hospital
Start Date
2020-04-10
Trial ID
NCT04328987
Treatments Being Tested
This study evaluates the efficacy and safety of tailored antithrombotic the...
Status
Completed
Location
Hallym University Sacred Heart Hospital
Start Date
2019-02-12
Trial ID
NCT03465644
Treatments Being Tested
This study is a prospective, single-center evaluation of the impact of the ...
Status
Unknown
Location
Heart Center Bad Krozingen
Start Date
2003-03
Trial ID
NCT00457236
Personalized therapy as prophylaxis in ischemic stroke patients is not yet ...
Status
Completed
Location
Zealand University Hospital, dept of neurology
Start Date
2015-11-01
Trial ID
NCT03385538
Treatments Being Tested
This is a prospective, randomized pilot study in patients undergoing Sugica...
Status
Terminated
Location
Cleveland Clinic
Start Date
2016-02
Trial ID
NCT02696226
Treatments Being Tested
The goal of this clinical trial is to learn about efficacy and safety of du...
Status
Unknown
Location
Sichuan Provincial People's Hospital
Start Date
2024-07-01
Trial ID
NCT06243133
In the elderly patients with hip fracture, some often take antiplatelet dru...
Status
Unknown
Location
Multiple Locations
Start Date
2020-01
Trial ID
NCT04165538
Treatments Being Tested
The purpose of this study is to assess whether abciximab is associated with...
Status
Completed
Location
Allgemeines Krankenhaus Wien
Start Date
2003-06
Trial ID
NCT00133250
Treatments Being Tested
Ticagrelor is a potent and fast-acting P2Y12-ADP receptor antagonist recomm...
Status
Completed
Location
APHM
Start Date
2018-10-28
Trial ID
NCT03357874
Treatments Being Tested